Scott Tarriff Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Scott Tarriff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Scott Tarriff. Scott Tarriff is a Director in CLINICAL DATA INC ($NOVI) and a Director in Synthetic Biologics, Inc. ($SYN) and a Director in ZIOPHARM ONCOLOGY INC ($ZIOP) and a CEO in EAGLE PHARMACEUTICALS, INC. ($EGRX) and a President and CEO in EAGLE PHARMACEUTICALS, INC. ($EGRX).
Address: 28 TUDOR ROSE TERRACE MAHWAH 07430 NJ
Companies in which Scott Tarriff is an Insider
CLINICAL DATA INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott Tarriff: Director
Holdings: 0 shares
Latest Transaction: Apr 14 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
EAGLE PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott Tarriff: President and CEO
Holdings: 1,546,323 shares
Current Value: $107,376,669
Latest Transaction: Jan 26 2021
$EGRX Market Capitalization: $1.09B
$EGRX Previous Close: $69.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Synthetic Biologics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott Tarriff: Director
Holdings: 300,000 shares
Current Value: $255,000
Latest Transaction: Dec 06 2019
$SYN Market Capitalization: $76.50M
$SYN Previous Close: $0.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ZIOPHARM ONCOLOGY INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Scott Tarriff: Director
Holdings: 4,186 shares
Current Value: $28,046
Latest Transaction: Jan 03 2020
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Scott Tarriff
Sentiment: All, NOVI, EGRX, SYN, ZIOP
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 26 2021 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Payment of Exercise | F | 47.70 | 4,631 | 220,899 | 1,546,323 | 1.6 M to 1.5 M (-0.30 %) |
| Jan 27 2020 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Payment of Exercise | F | 57.98 | 7,548 | 437,633 | 1,550,954 | 1.6 M to 1.6 M (-0.48 %) |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 59.80 | 145,700 | 8,712,132 | 145,700 | |
| Jan 07 2020 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Grant | A | 0.00 | 58,300 | 0 | 1,558,502 | 1.5 M to 1.6 M (+3.89 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 4.72 | 50,562 | 238,653 | 50,562 | |
| Dec 06 2019 | SYN | Synthetic Biologic ... | Tarriff Scott | Director | Option Exercise | A | 0.42 | 250,000 | 104,500 | 250,000 | |
| Mar 04 2019 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Sell | S | 51.81 | 12,428 | 643,895 | 1,525,177 | 1.5 M to 1.5 M (-0.81 %) |